Study protocol for the development and internal validation of Schizophrenia Prediction of Resistance to Treatment (SPIRIT): a clinical tool for predicting risk of treatment resistance to antipsychotics in first-episode schizophrenia
Danielle van der Windt,
Andrew Lawrence,
Richard Riley,
Paola Dazzan,
Saeed Farooq,
Tom Kingstone,
Miriam Hattle,
David Shiers,
Olesya Ajnakina,
Maria Antonietta Nettis
Affiliations
Danielle van der Windt
School of Medicine, Keele University, Keele, UK
Andrew Lawrence
4 Microbiology Department, SA Pathology, Adelaide, South Australia, Australia
Richard Riley
School of Medicine, Keele University, Keele, UK
Paola Dazzan
Department of Psychological Medicine, King’s College London, London, UK
Saeed Farooq
Research and Innovation Department, Midlands Partnership NHS Foundation Trust, Stafford, UK
Tom Kingstone
Research and Innovation Department, Midlands Partnership NHS Foundation Trust, Stafford, UK
Miriam Hattle
research associate
David Shiers
joint director of the National Development Network for Early Intervention
Olesya Ajnakina
1Behavioural Science and Health, University College London, London, UK
Maria Antonietta Nettis
Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, University of London, London, UK
